anti-AAV antibody product blogThe AAV n/a (Catalog #MBS830078) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The AAV antibody (intact) (biotin) reacts with To be determined by the end user and may cross-react with other species as described in the data sheet. MyBioSource\'s AAV can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Immunohistochemistry (IHC).
ELISA: 1:20. Researchers should empirically determine the suitability of the AAV n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal AAV intact particle antibody (biotin).
Biological Significance: Adeno-associated virus (AAV) is a small virus which infects humans and some other primate species. AAV is not currently known to cause disease and consequently the virus causes a very mild immune response. AAV can infect both dividing and non-dividing cells and may incorporate its genome into that of the host cell. These features make AAV a very attractive candidate for creating viral vectors for gene therapy, and for the creation of isogenic human disease models. Rep proteins bind ATP and to possess helicase activity. Tag/Conjugate: Biotin
Immunogen: AAV antibody (intact) (biotin) was raised in mouse using Adeno-associated virus capsid proteins and virus particles as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AAV are readily searchable from our website. Different antibodies against the same target such as AAV may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.